Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the ...

The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...

Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood.

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...

Mayo Clinic says this testing approach could help detect mesothelioma, a rare cancer that develops in the thin membranes that ...

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight ...

Malignant mesothelioma, which is often linked to asbestos exposure, is estimated to have caused over 25,000 deaths worldwide in 2022. The non-epithelioid form of the disease, which the CHMP's ...

Merck & Co. Inc.’s stock rose 2% premarket Tuesday, after the company reported positive results for a new, ...

Danny Abad Danny Abad, a proud veteran of The United States Navy, passed away August 19, 2024 from malignant mesothelioma. The son of Segundo P. Abad and Rosita Agsaway, ...

The endorsement supports the use of KEYTRUDA, in combination with pemetrexed and platinum chemotherapy, as a first-line treatment for adults with unresectable non-epithelioid malignant pleural ...

Find out where the icare Lung Bus mobile clinic will be stopping across New South Wales in 2025 to offer free screenings for those who have worked around dust.

[33] Recent trials using chemotherapy doublet regimens have shown that platinum agents, when used in combination with folate analogues, have improved cytotoxic activity against mesothelioma.